Esperion Therapeutics
ESPR
#6663
Rank
NZ$1.46 B
Marketcap
NZ$5.67
Share price
0.00%
Change (1 day)
33.46%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): NZ$0.13 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.41 Billion. In 2025 the company made an earning of NZ$0.11 Billion, an increase over its 2024 earnings that were of NZ$13.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.13 B20.03%
2025 NZ$0.11 B749.49%
2024 NZ$13.37 M-104.99%
2023 -NZ$0.27 Billion-15.03%
2022 -NZ$0.32 Billion-20.61%
2021 -NZ$0.4 Billion84.28%
2020 -NZ$0.22 Billion35.75%
2019 -NZ$0.16 Billion-55.71%
2018 -NZ$0.36 Billion19.57%
2017 -NZ$0.3 Billion125.39%
2016 -NZ$0.14 Billion51.43%
2015 -NZ$87.79 Million36.45%
2014 -NZ$64.34 Million43.55%
2013 -NZ$44.82 Million145.26%
2012 -NZ$18.28 Million
2002 -NZ$52.1 Million-7.81%
2001 -NZ$56.51 Million15.03%
2000 -NZ$49.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.30 B 8,600.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$9.20 B 6,407.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.91 Billion-736.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.11 Billion-176.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.34 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B 87.82%๐Ÿ‡บ๐Ÿ‡ธ USA